• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌动蛋白异构体失衡促进紫杉醇耐药三阴性乳腺癌细胞的肿瘤进展。

Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.

作者信息

Dugina Vera, Vasileva Maria, Khromova Natalia, Vinokurova Svetlana, Shagieva Galina, Mikheeva Ekaterina, Galembikova Aigul, Dunaev Pavel, Kudlay Dmitry, Boichuk Sergei, Kopnin Pavel

机构信息

A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119991, Russia.

Biological Faculty, M.V. Lomonosov Moscow State University, Moscow 119991, Russia.

出版信息

Int J Mol Sci. 2024 Apr 20;25(8):4530. doi: 10.3390/ijms25084530.

DOI:10.3390/ijms25084530
PMID:38674115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11049934/
Abstract

The widespread occurrence of breast cancer and its propensity to develop drug resistance highlight the need for a comprehensive understanding of the molecular mechanisms involved. This study investigates the intricate pathways associated with secondary resistance to taxol in triple-negative breast cancer (TNBC) cells, with a particular focus on the changes observed in the cytoplasmic actin isoforms. By studying a taxol-resistant TNBC cell line, we revealed a shift between actin isoforms towards γ-actin predominance, accompanied by increased motility and invasive properties. This was associated with altered tubulin isotype expression and reorganisation of the microtubule system. In addition, we have shown that taxol-resistant TNBC cells underwent epithelial-to-mesenchymal transition (EMT), as evidenced by Twist1-mediated downregulation of E-cadherin expression and increased nuclear translocation of β-catenin. The RNA profiling analysis revealed that taxol-resistant cells exhibited significantly increased positive regulation of cell migration, hormone response, cell-substrate adhesion, and actin filament-based processes compared with naïve TNBC cells. Notably, taxol-resistant cells exhibited a reduced proliferation rate, which was associated with an increased invasiveness in vitro and in vivo, revealing a complex interplay between proliferative and metastatic potential. This study suggests that prolonged exposure to taxol and acquisition of taxol resistance may lead to pro-metastatic changes in the TNBC cell line.

摘要

乳腺癌的广泛发生及其产生耐药性的倾向凸显了全面了解相关分子机制的必要性。本研究调查了三阴性乳腺癌(TNBC)细胞对紫杉醇继发性耐药相关的复杂途径,特别关注细胞质肌动蛋白异构体中观察到的变化。通过研究一种耐紫杉醇的TNBC细胞系,我们发现肌动蛋白异构体之间向以γ-肌动蛋白为主转变,同时细胞运动性和侵袭性增加。这与微管蛋白亚型表达的改变和微管系统的重组有关。此外,我们还表明,耐紫杉醇的TNBC细胞经历了上皮-间质转化(EMT),Twist1介导的E-钙黏蛋白表达下调和β-连环蛋白核转位增加证明了这一点。RNA谱分析显示,与未处理的TNBC细胞相比,耐紫杉醇的细胞在细胞迁移、激素反应、细胞-基质黏附以及基于肌动蛋白丝的过程的正调控方面显著增加。值得注意的是,耐紫杉醇的细胞增殖率降低,这与体外和体内侵袭性增加有关,揭示了增殖潜力和转移潜力之间的复杂相互作用。本研究表明,长期暴露于紫杉醇和获得紫杉醇耐药性可能导致TNBC细胞系发生促转移变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/c421c3158d67/ijms-25-04530-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/c61b2fef1deb/ijms-25-04530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/902fd5a4dd30/ijms-25-04530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/f6e9ee7120cd/ijms-25-04530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/e18ff63a54bb/ijms-25-04530-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/4f8df0df13a1/ijms-25-04530-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/c421c3158d67/ijms-25-04530-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/c61b2fef1deb/ijms-25-04530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/902fd5a4dd30/ijms-25-04530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/f6e9ee7120cd/ijms-25-04530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/e18ff63a54bb/ijms-25-04530-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/4f8df0df13a1/ijms-25-04530-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/11049934/c421c3158d67/ijms-25-04530-g006.jpg

相似文献

1
Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.肌动蛋白异构体失衡促进紫杉醇耐药三阴性乳腺癌细胞的肿瘤进展。
Int J Mol Sci. 2024 Apr 20;25(8):4530. doi: 10.3390/ijms25084530.
2
Role of inhibitor of yes-associated protein 1 in triple-negative breast cancer with taxol-based chemoresistance.YAP1 抑制剂在紫杉醇类化疗耐药三阴性乳腺癌中的作用。
Cancer Sci. 2019 Feb;110(2):561-567. doi: 10.1111/cas.13888. Epub 2019 Jan 4.
3
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.BRCA1-IRIS失活克服三阴性乳腺癌中的紫杉醇耐药性。
Breast Cancer Res. 2015 Jan 13;17(1):5. doi: 10.1186/s13058-014-0512-9.
4
Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.小豆蔻明,一种查尔酮,通过下调Wnt/β-连环蛋白信号级联反应和逆转上皮-间质转化来抑制人三阴性乳腺癌细胞的侵袭性。
Biofactors. 2017 Mar;43(2):152-169. doi: 10.1002/biof.1315. Epub 2016 Sep 1.
5
Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.Notch1 抑制通过直接下调三阴性乳腺癌细胞中 MCAM 逆转 EMT 和顺铂化疗耐药性。
Int J Cancer. 2020 Jul 15;147(2):490-504. doi: 10.1002/ijc.32911. Epub 2020 Feb 15.
6
New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells.紫杉醇耐药的三阴性乳腺癌细胞中基因表达改变的新见解。
Cell Physiol Biochem. 2020 Jul 4;54(4):648-664. doi: 10.33594/000000246.
7
USP18 reduces paclitaxol sensitivity of triple-negative breast cancer via autophagy.USP18通过自噬降低三阴性乳腺癌对紫杉醇的敏感性。
Biochem Biophys Res Commun. 2022 Apr 9;599:120-126. doi: 10.1016/j.bbrc.2022.02.048. Epub 2022 Feb 12.
8
JAK2 regulates paclitaxel resistance in triple negative breast cancers.JAK2 调控三阴性乳腺癌对紫杉醇的耐药性。
J Mol Med (Berl). 2021 Dec;99(12):1783-1795. doi: 10.1007/s00109-021-02138-3. Epub 2021 Oct 9.
9
RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.RNA 结合蛋白 MSI2 异构体在三阴性乳腺癌进展中的表达和调控。
J Exp Clin Cancer Res. 2020 May 24;39(1):92. doi: 10.1186/s13046-020-01587-x.
10
Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.三重阴性乳腺癌细胞对新型细胞抑制剂四氢异喹啉与紫杉醇反应的转录组谱分析。
Int J Mol Sci. 2021 Jul 19;22(14):7694. doi: 10.3390/ijms22147694.

引用本文的文献

1
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer.基于深度学习的多组学分析用于预测癌症未来转移
bioRxiv. 2025 May 22:2025.05.16.654579. doi: 10.1101/2025.05.16.654579.
2
Divergent Contribution of Cytoplasmic Actins to Nuclear Structure of Lung Cancer Cells.细胞质肌动蛋白对肺癌细胞核结构的不同贡献
Int J Mol Sci. 2024 Dec 19;25(24):13607. doi: 10.3390/ijms252413607.
3
Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis.

本文引用的文献

1
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis.转移性三阴性乳腺癌一线治疗的疗效与安全性:一项网状Meta分析。
Cancer Pathog Ther. 2023 Jun 13;2(2):81-90. doi: 10.1016/j.cpt.2023.06.002. eCollection 2024 Apr.
2
My battle with cancer. Part 1.我与癌症的抗争。第一部分。
Oncoscience. 2024 Jan 3;11:1-14. doi: 10.18632/oncoscience.593. eCollection 2024.
3
Taxol acts differently on different tubulin isotypes.紫杉醇对不同的微管蛋白异构体作用方式不同。
乳腺癌细胞对激素疗法和靶向疗法的耐药性与NR6A1轴的失活相关。
Cancer Drug Resist. 2024 Nov 23;7:48. doi: 10.20517/cdr.2024.69. eCollection 2024.
Commun Biol. 2023 Sep 16;6(1):946. doi: 10.1038/s42003-023-05306-y.
4
Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities.基于组学的化学耐药性三阴性乳腺癌细胞分析揭示了新的代谢脆弱性。
Cells. 2022 Aug 31;11(17):2719. doi: 10.3390/cells11172719.
5
Unique and redundant functions of cytoplasmic actins and nonmuscle myosin II isoforms at epithelial junctions.细胞质肌动蛋白和非肌肉肌球蛋白 II 同工型在细胞连接中的独特和冗余功能。
Ann N Y Acad Sci. 2022 Sep;1515(1):61-74. doi: 10.1111/nyas.14808. Epub 2022 Jun 7.
6
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.抗微管蛋白药物的耐药性:从长春花生物碱到埃坡霉素
Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019.
7
Impaired Expression of Cytoplasmic Actins Leads to Chromosomal Instability of MDA-MB-231 Basal-Like Mammary Gland Cancer Cell Line.细胞质肌动蛋白表达缺陷导致 MDA-MB-231 基底样乳腺腺癌细胞系的染色体不稳定性。
Molecules. 2021 Apr 8;26(8):2151. doi: 10.3390/molecules26082151.
8
Resistance to Intervention: Paclitaxel in Breast Cancer.耐药性干预:紫杉醇治疗乳腺癌。
Mini Rev Med Chem. 2021;21(10):1237-1268. doi: 10.2174/1389557520999201214234421.
9
Persistent Cancer Cells: The Deadly Survivors.持久癌细胞:致命幸存者。
Cell. 2020 Nov 12;183(4):860-874. doi: 10.1016/j.cell.2020.10.027.
10
Divergent Impact of Actin Isoforms on Division of Epithelial Cells.肌动蛋白异构体对上皮细胞分裂的影响存在差异。
Biochemistry (Mosc). 2020 Sep;85(9):1072-1063. doi: 10.1134/S0006297920090072.